Following expectations that legal vape and edible products would hit shelves in mid-December, it now appears that the launch of “cannabis 2.0” products in Canada will be delayed.

While Dec. 16 is the first official date that companies can enter new items into distribution channels, those product types aren’t likely to land on dispensary shelves until January.

Canopy Growth Corporation (TSX: WEED; NYSE: CGC) today announced a staggered launch for newly licensed product types, with availability to vary between locations during a months-long rollout.

A limited selection of new chocolate, infused beverage, and vape types will first arrive throughout January, with additional options coming in February and beyond.

Tokyo Smoke and Tweed Bakerstreet infused chocolate products with a THC focus will launch first early next month. CBD variants on those chocolates are slated to hit shelves at the end of January, followed by the Bean & Bud chocolate brand in February.

On the beverage side, Canopy is gearing up to launch both Tweed Houndstooth & Soda as well as the Houseplant Grapefruit drinks next month. The latter is part of the company’s previously announced collaboration with Hollywood comedy icon Seth Rogen.

After those drinks hit shelves, additional infused beverage launches are expected through the Quatreau and Deep Space brands.

Vape cartridges and pens from the Tweed and Van Der Pop lines will finally arrive for Canadian consumers towards the end of next month. After those items are available, a line of recyclable, single use Juju Joints — which are also Bluetooth-enabled — will come at an unknown date down the line.

The rollout of vape products in Canada is expected to see a particularly rocky launch after a lung disease health scare in North America prompted two provincial governments in Canada to ban vape sales.

Canopy Growth commented on that development this morning:

The company recognizes the recent announcements by the provinces of Newfoundland & Labrador and Quebec delaying the launch of vape products in those provinces; as provincial buyers increase their level of scrutiny on the products they sell, the company will continue to work to meet the highest standards of safety, product quality and transparency for consumers.

The Centers For Disease Control issued an early report from ongoing investigations stating the most likely cause of the vape-related lung disease is vitamin E acetate found in unlicensed, black market THC products.